切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 378 -382. doi: 10.3877/cma.j.issn.1674-3253.2021.05.004

临床研究

68Ga-PSMA-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值
秦露平1, 吕杰2, 李名钊3, 李建芳1, 谢良骏1, 李锦萍1, 程木华1,()   
  1. 1. 510630 广州,中山大学附属第三医院核医学科
    2. 510120 广州医科大学附属第一医院核医学科
    3. 510630 广州,中山大学附属第三医院泌尿外科
  • 收稿日期:2021-06-15 出版日期:2021-10-01
  • 通信作者: 程木华

The value of 68Ga-PSMA-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy

Luping Qin1, Jie Lv2, Mingzhao Li3, Jianfang Li1, Liangjun Xie1, Jinping Li1, Muhua Cheng1,()   

  1. 1. Department of Nuclear Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
    2. Department of Nuclear Medicine, the First Affiliated Hospital of Guangzhou Medical University, 510120 Guangzhou, China
    3. Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
  • Received:2021-06-15 Published:2021-10-01
  • Corresponding author: Muhua Cheng
引用本文:

秦露平, 吕杰, 李名钊, 李建芳, 谢良骏, 李锦萍, 程木华. 68Ga-PSMA-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(05): 378-382.

Luping Qin, Jie Lv, Mingzhao Li, Jianfang Li, Liangjun Xie, Jinping Li, Muhua Cheng. The value of 68Ga-PSMA-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(05): 378-382.

目的

分析68Ga-前列腺特异性膜抗(PSMA)-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值。

方法

回顾性纳入本院行前列腺癌根治术的患者24例。患者注射显像剂后60 min行68Ga-PSMA-11 PET/CT全身标准显像及180 min行局部盆腔延迟显像。比较标准显像及延迟显像探测盆腔复发病灶数目、大小、最大标准摄取值(SUVmax)及靶/本比(T/B)。

结果

24例患者中,盆腔复发患者17例。复发患者中标准显像阳性15例,延迟显像阳性17例。无复发患者7例,标准显像及延迟显像均呈阴性。标准显像探测盆腔复发灵敏度为82.24%(15/17),延迟显像灵敏度为100.0%(17/17),两者差异无统计学意义(χ2=2.125,P=0.145)。延迟显像比标准显像多探测10个盆腔阳性病灶。延迟显像额外发现的盆腔病灶直径4(3,8) mm比标准显像发现的盆腔病灶直径8(7,12) mm更小(U=94,P=0.004)。延迟显像病灶SUVmax10.08(6.58,15.50)与标准显像7.89(4.87,15.26)相当(U=1204,P=0.234),但延迟显像病灶T/B值55.90(30.45,109.27)明显高于标准显像32.89(21.67,55.07) (U=840,P=0.0005)。

结论

前列腺癌根治术后68Ga-PSMA-11 PET/CT延迟显像可以探测更多更小的盆腔复发病灶。

Objective

To analyze the value of 68Ga-Prostate-specific membrane antigen (PSMA)-11 PET/CT delayed imaging in the detection of pelvic recurrence after radical prostatectomy.

Methods

Twenty-four patients who underwent radical prostatectomy at our institution were retrospectively enrolled in the study. The patients received 68Ga-PSMA-11 PET/CT whole-body standard imaging at 60 min and pelvic delayed imaging at 180 min after intravenous injection of radiopharmaceutical. The number, size, maximum standard uptake (SUVmax) and target-to-background ratio (T/B) of pelvic recurrent lesions were compared between standard imaging and delayed imaging.

Results

Pelvic recurrence occurred in 17 of the 24 patients. Of the recurrent patients, standard imaging was positive in 15 cases and delayed imaging was positive in 17 cases. There were 7 cases without recurrence, and both standard imaging and delayed imaging were negative. There was no statistical difference (χ2=2.125, P=0.145) in the sensitivity of detecting pelvic recurrence between standard imaging (82.24%, 15/17) and delayed imaging (100.00%, 17/17). Delayed imaging detected 10 more pelvic positive lesions than standard imaging. The diameter 4(3, 8) mm of additional pelvic lesion detected by delayed imaging was smaller than that 8(7, 12) mm of pelvic lesion detected by standard imaging (U=94, P=0.004). The SUVmax 10.08(6.58, 15.50) of delayed imaging was similar to that of standard imaging 7.89(4.87, 15.26) (U=1204, P=0.234), however the T/B value of delayed imaging 55.90(30.45, 109.27) was significantly higher than that of standard imaging 32.89(21.67, 55.07) (U=840, P=0.0005).

Conclusion

68Ga-PSMA-11 PET/CT delayed imaging can detect more and smaller pelvic recurrent lesions after radical prostatectomy.

图1 68Ga-PSMA-11 PET/CT延迟显像额外发现髂骨病灶 注:a为67岁,男性患者,68Ga-PSMA-11 PET/CT标准显像右侧髂骨见一高密度小结节影,边界清晰,直径为4 mm,未见放射性浓聚,本底SUVmean为0.44;b为该患者68Ga-PSMA-11 PET/CT延迟显像右侧髂骨病灶见放射性浓聚,SUVmax为2.65,本底SUVmean为0.17,T/B为15.59;c为该患者经过内分泌治疗后1年余复查68Ga-PSMA-11 PET/CT标准显像,原右侧髂骨病灶直径增大至9 mm,见放射性浓聚,SUVmax为32.47,本底SUVmean为0.40,T/B为81.18
[1]
Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3]
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
[4]
Eiber M, Kroenke M, Wurzer A, et al. 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy[J]. J Nucl Med, 2020, 61(5): 696-701.
[5]
瞿旻, 高旭, 侯建国, 等. 前列腺癌患者根治术后生化复发危险因素的单中心研究[J]. 中华泌尿外科杂志, 2015, 36(8): 573-577.
[6]
Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 1014-1024.
[7]
田蓉蓉, 赵铭, 周洁, 等. 18F-PSMA-1007 PET/CT对低PSA水平前列腺癌复发的检测价值[J]. 中华核医学与分子影像杂志, 2020, 40(10): 589-594.
[8]
周文瑶, 张俊. 前列腺癌PSMA PET显像剂研究进展[J]. 中华核医学与分子影像杂志, 2020, 40(12): 755-760.
[9]
Cheng G, Torigian DA, Zhuang H, et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?[J]. Eur J Nucl Med Mol Imaging, 2013, 40(5): 779-787.
[10]
Schmuck S, Nordlohne S, von Klot C, et al. Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 960-968.
[11]
Sahlmann C, Meller B, Bouter C, et al. Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(5): 898-905.
[12]
Schmuck S, Mamach M, Wilke F, et al. Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer[J]. Clin Nucl Med, 2017, 42(6): e286-e293.
[13]
Beheshti M, Manafi-Farid R, Geinitz H, et al. Multiphasic 68Ga-PSMA PET/CT in the detection of early recurrence in prostate cancer patients with a psa level of less than 1 ng/ml: a prospective study of 135 patients[J]. J Nucl Med, 2020, 61(10): 1484-1490.
[14]
Derlin T, Weiberg D, von Klot C, et al. (68)Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging[J]. Eur Radiol, 2016, 26(12): 4345-4353.
[15]
Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of hybrid (6)(8)ga-psma ligand pet/ct in 248 patients with biochemical recurrence after radical prostatectomy[J]. J Nucl Med, 2015, 56(5): 668-674.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[6] 高建新, 王啸飞, 于淼, 路夷平. 局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 539-543.
[7] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[10] 谢汶歆, 马乐, 刘晔, 曹晓明, 张万春. 前列腺特异性膜抗原PET/CT在肾癌诊疗中的应用价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 514-519.
[11] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[12] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[13] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[14] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要